GLP-1 drugs receive FDA warning over rare eye condition risk
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.” STAT+ reported the alert as part of its biotech coverage on obesity treatments and agency oversight.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu